Gossamer Bio, Inc. (GOSS)

2.585 +0.06 (+2.58%) USD  |  NASDAQ  |  Jan 20, 10:49
More

Gossamer Bio Total Long Term Liabilities (Quarterly)

Total Long Term Liabilities (Quarterly) Chart

View Total Long Term Liabilities (Quarterly) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Liabilities (Quarterly) Range, Past 5 Years

View Total Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Liabilities (Quarterly) Benchmarks

View Total Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. --
XOMA Royalty Corp. Upgrade
Rezolute, Inc. --
Axsome Therapeutics, Inc. --
Crinetics Pharmaceuticals, Inc. --